$Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma$

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

Summary Background: Dexamethasone, cytarabine (ara-C), and cisplatin (DHAP) can be used effectively to treat patients with non-Hodgkin's lymphoma (NHL). We hypothesized that substitution of cisplatin by oxaliplatin (L-OHP) could result in less toxicity and greater efficacy. L-OHP is active in p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2001-10, Vol.12 (10), p.1439-1443
Hauptverfasser:	Machover, D., Delmas-Marsalet, B., Misra, S.C., Gumus, Y., Goldschmidt, E., Schilf, A., Frénoy, N., Emile, J.-F., Debuire, B., Guettier, C., Farrokhi, P., Boulefdaoui, B., Norol, F., Parquet, N., Ulusakarya, A., Jasmin, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomarkers, Tumor - analysis Chemotherapy Cytarabine - administration & dosage dexamethasone Dexamethasone - administration & dosage Disease-Free Survival Drug Resistance, Neoplasm Female Granulocyte Colony-Stimulating Factor - administration & dosage high-dose cytarabine Humans Infusions, Intravenous Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - pathology Male Medical sciences Middle Aged non-Hodgkin's lymphoma Organoplatinum Compounds - administration & dosage oxaliplatin Pharmacology. Drug treatments Recurrence salvage therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!